Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
29.40    -0.20 (-0.68%)
Bid:
29.38
Ask:
29.60
Spread: 0.22 (0.749%)
Market Cap: £466.54m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

AGM trading update and Frasers Group partnership

24 Jun 2024 07:00

RNS Number : 4907T
THG PLC
24 June 2024
 

24 June 2024

 

THG PLC

 

AGM Trading Statement

 

 

Group performance on track, FY 2024 guidance unchanged

 

Multi-year THG Ingenuity & Myprotein partnership agreed with Frasers Group PLC

 

 

 

THG PLC ("THG" or the "Group") provides the following update on trading ahead of its Annual General Meeting (AGM) later today.

 

All comparative figures are continuing CCY unless otherwise stated.

 

The Group has made further progress in H1 2024 in line with previous revenue guidance, and Q2 will represent the third consecutive quarter of year-on-year (YoY) revenue growth. The Group's performance is underpinned by positive trading within the Beauty, external Ingenuity and offline Nutrition businesses, which have helped offset continuing FX headwinds within Asia. Guidance for FY 2024 remains unchanged[1].

 

 

THG Beauty

 

· Positive momentum from Q4 2023 continued into H1 2024 with a strong recovery in beauty manufacturing following the prior year industry de-stocking.

 

· Customer engagement continues to strengthen across THG Beauty with a +45% increase in app downloads YoY, and increasing loyalty programme membership.

 

 

THG Nutrition

 

· The rebranding across the Myprotein range is progressing well, with c.80% of products by online revenue planned to be under new branding by the end of Q3 2024. Offline retailers are responding especially well to the new brand positioning, with major listings now live across key territories. These include both Costco and GNC in the US, as well as across major UK grocers, Boots and WHSmith.

· The introduction of the new packaging and brand designs have been carefully managed to avoid significant wastage enabling continued sell-through online. Developing offline relationships have also been protected by avoiding the use of clearance channels to speed up the rebranding process.

 

· This careful approach across such an extensive product range creates some temporary availability gaps, while customers naturally prefer new and refreshed packaging. This is a major factor in the online YoY sales decline.

 

 

THG Ingenuity

 

· THG Ingenuity momentum continues to strengthen, underpinned by an acceleration of third party revenue growth in Q2 vs. Q1, and +30% monthly recurring revenue (June 2024).

 

· H1 revenue growth has been broad based across both new and existing clients, and technology, digital marketing and fulfilment services.

 

 

Partnership with Frasers Group PLC ("Frasers Group")

 

 THG and Frasers Group have agreed a partnership across several areas.

 

· THG Ingenuity and Frasers Group have entered a multi-year Ingenuity agreement including courier management services and re-platforming the Frasers Group's Australian fulfilment and logistics operations.

 

· Frasers Group's credit and loyalty platform, Frasers Plus, is now integrated into Ingenuity's checkout and will soon be available to both THG's Beauty and Nutrition customers, as well as to Ingenuity clients. 

 

· A curated range of Myprotein products to be launched instore at Sports Direct, including the Hyrox x Myprotein range. Myprotein is not only the world's No1 online sports nutrition brand but is also the fastest growing sports nutrition brand in the UK retail market[2]. The launch across Sports Direct stores further supports the success of the recent rebrand and the offline growth potential of the brand. Launching collaboration products through Sports Direct further broadens the Myprotein brand appeal, bringing the rapidly growing Hyrox community to both Myprotein and Sports Direct alike.

 

· THG has agreed to sell its portfolio of luxury goods websites, including www.coggles.com, to the Frasers Group. Ingenuity will continue to support the brand portfolio across technology, digital marketing and fulfilment services post disposal.

 

· From a standing start almost 11 years ago, THG's luxury division grew to c. £43m sales and broadly break-even for FY 2023, despite a broader challenging luxury market. This has only been possible through the hard work and dedication of THG's luxury team, to whom we all want to extend our thanks and gratitude.

 

 

UK listing regime review

 

The FCA's listing regime review is expected to conclude shortly. As previously indicated, the Board will analyse the outcome of the FCA's review following its conclusion and assess transferring to the single listing category of Equity Shares (commercial companies).

 

 

For further information please contact:

 

Investor enquiries:

Greg Feehely, SVP Investor Relations

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

 

Media enquiries:

Powerscourt - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Victoria Palmer-Moore/ Russ Lynch

thg@powerscourt-group.com

 

THG PLC

Viki Tahmasebi

 

 

 

Viki.tahmasebi@thg.com

 

 

ENDS

Notes to editors

THG PLC operates three distinct businesses in Beauty, Nutrition and Ingenuity, each scaled from the UK to hold global leading positions in their respective sectors.


[1] Adjusted EBITDA range of £133.8m to £156.5m as dated 28.05.24 and available at Analyst Consensus - THG.com

[2] Source: Nielsen Total Market, last 12 weeks to 28/05/2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDLGUDDGSX
Date   Source Headline
24th Jun 20262:45 pmRNSResult of AGM
24th Jun 20267:00 amRNSAGM Trading Statement
12th Jun 20267:00 amRNS-R€445m Term Loan B trading above par at record high
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.